| Literature DB >> 31432180 |
Jiangtao Liu1, Yulin Li1.
Abstract
The present study aimed to investigate genes and transcription factors (TFs) that may contribute to neuroblastoma (NB) development. The GSE78061 dataset that included 25 human NB cell lines and four retinal pigment epithelial cell lines was used to analyze differentially expressed genes (DEGs) between groups. Functional enrichment analysis and protein‑protein interaction (PPI) network analysis were performed for the identified DEGs. Additionally, submodule analysis and TF‑target regulatory networks were conducted. The relative mRNA expression levels of mitogen‑activated protein kinase 10 (MAPK10), tubulin β 2B class IIb (TUBB2B), RAS like family 11 member B (RASL11B) and integrin subunit α 2 (ITGA2) in the NB cell line SH‑SY5Y were compared with retinal pigment epithelial cell lines. A set of 386 upregulated and 542 downregulated DEGs were obtained. Upregulated DEGs were significantly associated with the 'neuron migration' and 'dopaminergic synapse signaling' pathways, whereas, downregulated DEGs were primarily involved in 'focal adhesion' such as ITGA2 and ITGA3. In the PPI networks analyzed, MAPK10, dopa decarboxylase (DDC), G protein subunit γ 2 (GNG2), paired like homeobox 2B (PHOX2B), TUBB2B, RASL11B, and ITGA2 were hub genes with high connectivity degrees. Additionally, PHOX2B was predicted to be a TF regulating TUBB2B in the regulatory network. The expressions of MAPK10, TUBB2B, RASL11B and ITGA2 were detected by reverse transcription‑quantitative polymerase chain reaction in the NB cell line SH‑SY5Y, and were consistent with the present bioinformatics results, suggesting that MAPK10, DDC, GNG2, PHOX2B, TUBB2B, RASL11B, ITGA2 and ITGA3 may contribute to NB development. Additionally, the present study identified a novel significant association between the increased expression levels of MAPK10, TUBB2B and RASL11B, and NB cells.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31432180 PMCID: PMC6755162 DOI: 10.3892/mmr.2019.10589
Source DB: PubMed Journal: Mol Med Rep ISSN: 1791-2997 Impact factor: 2.952
Primer sequences for the validated genes.
| Primer name | Primer sequence (5′-3′) |
|---|---|
| ITGA2-F | GTGGCTTTCCTGAGAACCGA |
| ITGA2-R | GATTCCCACATTGCTGTGCC |
| MAPK10-F | TGGTGACACGTTATTACAGAGC |
| MAPK10-R | GGCCGATTCTCCACATAGTTTCT |
| TUBB2B-F | TACTTTAGGTGTGCGCTGGG |
| TUBB2B-R | GAGGACACCATTCCGACACA |
| RALS11B-F | CGGTTCCTCACCAAACGATTC |
| RALS11B-R | GGCTGTTCTCATGGACCTGAA |
| GAPDH-F | TGACAACTTTGGTATCGTGGAAGG |
| GAPDH-R | AGGCAGGGATGATGTTCTGGAGAG |
MAPK10, mitogen-activated protein kinase 10; TUBB2B, tubulin β 2B class IIb; RASL11B, RAS like family 11 member B; ITGA2, integrin subunit α 2; F, forward; R, reverse.
Figure 1.Hierarchical cluster map of DEGs. Horizontal axis indicates the names of each sample, whereas, the right vertical axis indicates clusters of DEGs. Gradual change from blue to orange indicates the expression values, from decreased to increased expression levels. DEGs, differentially expressed genes.
Top five enriched MF, CC and BP GO terms, and KEGG pathways for upregulated DEGs and downregulated DEGs.
| A, Upregulated DEGs | ||||
|---|---|---|---|---|
| Category | Term | Count | P-value | Examples of genes |
| KEGG | hsa05034:Alcoholism | 11 | 2.84×10−4 | HIST1H3J, HIST1H3F, HIST2H4A, GNG4 and HIST1H3I |
| KEGG | hsa04728:Dopaminergic synapse | 9 | 6.07×10−4 | DDC, KIF5A, GNG2, MAPK10 and GNG4 |
| KEGG | hsa00330:Arginine and proline metabolism | 6 | 8.31×10−4 | CKMT1A, CKMT1B, ARG2, MAOA and ALDH2 |
| KEGG | hsa04725:Cholinergic synapse | 8 | 1.27×10−3 | GNAO1, CHRNB4, SLC18A3, GNG2 and CHRNA7 |
| KEGG | hsa05032:Morphine addiction | 7 | 2.27×10−3 | GNAO1, PDE3B, PDE10A, GNG2 and GNG4 |
| MF | GO:0015276:Ligand-gated ion channel activity | 7 | 4.32×10−5 | CHRNB4, CHRNA7, CHRNB2, CHRFAM7A and CHRNA3 |
| MF | GO:0042166:Acetylcholine binding | 6 | 9.4×10−5 | CHRNB4, SLC18A3, CHRNA7, CHRNB2 and CHRNA3 |
| MF | GO:0004889:Acetylcholine-activated cation-selective channel activity | 5 | 7.32×10−4 | CHRNB4, CHRNA7, CHRNB2, CHRFAM7A and CHRNA3 |
| MF | GO:0015464:Acetylcholine receptor activity | 5 | 7.32×10−4 | CHRNB4, CHRNA7, CHRNB2, CHRFAM7A and CHRNA3 |
| MF | GO:0008017:Microtubule binding | 12 | 1.57×10−3 | KIF1A, KIF5B, KIF5A, MAPT and KIF5C |
| CC | GO:0030424:Axon | 23 | 1.18×10−10 | DDC, RET, SYT4, STMN2 and ATL1 |
| CC | GO:0043005:Neuron projection | 23 | 4.20×10−10 | CADM1, RAB39B, STMN2, KIF5A and SLC6A2 |
| CC | GO:0030054:Cell junction | 30 | 6.16×10−9 | SEPT3, SYT4, GABRB3, GRIK2 and SYP |
| CC | GO:0030426:Growth cone | 11 | 5.07×10−5 | TSHZ3, STMN2, MAPT, LRRTM1 and STMN4 |
| CC | GO:0044295:Axonal growth cone | 5 | 2.67×10−4 | FLRT3, KIF5B, PTCH1, L1CAM and OLFM1 |
| BP | GO:0007399:Nervous system development | 21 | 6.05×10−7 | SCN3B, FGF14, DPYSL5, L1CAM and CNTFR |
| BP | GO:0001764:Neuron migration | 13 | 7.00×10−7 | ASCL1, GATA2, PHOX2B, TUBB2B and GATA3 |
| BP | GO:0035095:behavioral response to nicotine | 5 | 1.48×10−5 | CHRNB4, CHRNA7, CHRNB2, CHRFAM7A and CHRNA3 |
| BP | GO:0060384:Innervation | 6 | 1.65×10−5 | RET, SULF2, GABRB3, RNF165 and ISL1 |
| BP | GO:0048485:Sympathetic nervous system development | 5 | 1.46×10−4 | PHOX2A, PHOX2B, ASCL1, HAND2 and GATA3 |
| KEGG | hsa05205:Proteoglycans in cancer | 27 | 8.81×10−10 | ITGA2, ITGB5, CD44, ITGA5 and THBS1 |
| KEGG | hsa04512:ECM-receptor interaction | 17 | 1.25×10−8 | COL4A2, COL4A1, ITGA11, ITGA2 and ITGB5 |
| KEGG | hsa04510:Focal adhesion | 25 | 3.67×10−8 | ITGA11, ITGA2, ITGB5, ITGA3 and ITGA4 |
| KEGG | hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC) | 14 | 3.21×10−7 | ITGA11, ITGA2, GJA1, ITGB5 and ITGA3 |
| KEGG | hsa05410:Hypertrophic cardiomyopathy (HCM) | 14 | 9.98×10−7 | IL6, ITGB8, ITGA5, ITGAV and ITGA7 |
| MF | GO:0001968:Fibronectin binding | 11 | 6.48×10−10 | CTSK, CTGF, ITGAV, CCDC80 and FSTL3 |
| MF | GO:0005518:Collagen binding | 14 | 5.31×10−9 | ADGRG6, ITGA11, ITGA2, SMAD3 and ITGA3 |
| MF | GO:0005509:Calcium ion binding | 49 | 5.65×10−9 | LTBP1, LTBP2, LTBP3, FSTL1 and EDIL3 |
| MF | GO:0005178:Integrin binding | 17 | 2.01×10−8 | FBN1, ITGA2, ITGA3, EDIL3 and CD151 |
| MF | GO:0008201:Heparin binding | 19 | 3.16×10−7 | BMP4, CCL2, LTBP2, LXN and FBN1 |
| CC | GO:0009986:Cell surface | 59 | 1.21×10−19 | MICB, MICA, CSPG4, TLR3 and TLR4 |
| CC | GO:0005925:Focal adhesion | 50 | 1.40×10−19 | ITGA11, ITGA2, ITGB5, ITGA3 and ITGA4 |
| CC | GO:0031012:Extracellular matrix | 41 | 2.48×10−17 | LTBP1, LTBP2, LTBP3, IGFBP7 and POSTNS |
| CC | GO:0005886:Plasma membrane | 184 | 4.83×10−14 | F2RL2, SLC9A7, MICB, MICA and VCL |
| CC | GO:0070062:Extracellular exosome | 135 | 4.58×10−12 | CHMP4C, LTBP2, LTBP3, CSPG4 and FSTL1 |
| BP | GO:0007155:Cell adhesion | 51 | 6.51×10−17 | IGFBP7, POSTN, EDIL3, CD151 and VCL |
| BP | GO:0030198:Extracellular matrix organization | 31 | 2.15×10−14 | ITGA11, ITGB5, POSTN, ABI3BP and CD44 |
| BP | GO:0035987:Endodermal cell differentiation | 13 | 2.05×10−12 | HMGA2, COL8A1, MMP14, MMP2 and FN1 |
| BP | GO:0010628:Positive regulation of gene expression | 32 | 8.90×10−12 | ACTA2, SMAD3, ITGA3, INHBA and TFAP2A |
| BP | GO:0001666:Response to hypoxia | 23 | 2.27×10−9 | MMP14, MMP2, TGFB1, TGFB2 and THBS1 |
DEGs, differentially expressed genes; MF, molecular function; CC, cellular component; BP, biological process; KEGG, Kyoto Encyclopedia of Genes and Genomes; GO, Gene Ontology.
Figure 2.Top five enriched groups in each functional enrichment analysis. (A) Upregulated DEGs. (B) Downregulated DEGs. MF, molecular function; CC, cellular component; BP, biological process; KEGG, Kyoto Encyclopedia of Genes and Genomes; DEGs, differentially expressed genes; GO, Gene Ontology.
Figure 3.Protein-protein interaction network of upregulated differentially expressed genes. The top 15 nodes ranked by connectivity degrees are highlighted in blue. Nodes represent genes, and edges connect the nodes to indicate their associations. The node size represents connectivity degree.
Figure 4.Protein-protein interaction network for downregulated differentially expressed genes. The top 15 nodes ranked by degree values are highlighted in blue. Nodes represent genes, and edges connecting the nodes indicate their associations. The node size represents the respective connectivity degree.
Topological property scores for nodes in the protein-protein interaction network, top 20 upregulated DEGs and top 20 downregulated DEGs.
| A, Upregulated DEGs | |
|---|---|
| Node | Degree |
| GNAO1 | 17 |
| ISL1 | 13 |
| MAPK10 | 13 |
| ASCL1 | 13 |
| RET | 13 |
| NPY | 12 |
| TUBB2B | 11 |
| GNG2 | 11 |
| CHGA | 11 |
| RASL11B | 10 |
| GATA3 | 10 |
| PTCH1 | 9 |
| PHOX2B | 9 |
| DDC | 9 |
| MAP2 | 8 |
| LGR5 | 8 |
| GATA2 | 8 |
| PHOX2A | 8 |
| HAND2 | 8 |
| PDE10A | 7 |
| ITGA2 | 58 |
| TGFB1 | 58 |
| MMP2 | 55 |
| IL6 | 53 |
| RAC1 | 46 |
| SMAD3 | 44 |
| ITGB5 | 41 |
| FN1 | 40 |
| THBS1 | 39 |
| BMP4 | 35 |
| SERPINE1 | 35 |
| ITGAV | 34 |
| EDN1 | 32 |
| CAV1 | 32 |
| CTGF | 31 |
| ACTA2 | 31 |
| FURIN | 30 |
| CD44 | 28 |
| MMP14 | 27 |
| MET | 27 |
DEGs, differentially expressed genes.
Figure 5.Result for module analysis. ITGA, integrin subunit α; ITGB, integrin subunit β; COL4A1, collagen type IV α 1 chain; FN1, fibronectin 1; THBS1, thrombospondin 1.
Figure 6.Integrative regulatory network of TF-targets. The diamond-shaped nodes represent TFs and circles represent target genes. Gray indicates downregulated genes and white indicates upregulated genes. TF, transcription factor.
Topological property scores for the top 20 nodes in the TF-target regulatory network.
| A, Upregulated DEGs | ||
|---|---|---|
| Node | Description | Degree |
| HEY1 | TF | 4 |
| PHOX2B | TF | 2 |
| HOXC6 | TF | 2 |
| TFAP2A | TF | 9 |
| MITF | TF | 8 |
| SMAD3 | TF | 6 |
| RUNX1 | TF | 5 |
| PAX6 | TF | 5 |
| AHR | TF | 5 |
| VDR | TF | 4 |
| RUNX2 | TF | 4 |
| FOXP2 | TF | 4 |
| FLI1 | TF | 4 |
| MMP2 | Target | 3 |
| MET | Target | 3 |
| IGFBP3 | Target | 3 |
| IL6 | Target | 3 |
| WWTR1 | TF | 2 |
| OTX2 | TF | 2 |
| NR3C1 | TF | 2 |
TF, transcription factor; DEGs, differentially expressed genes.
Figure 7.RT-qPCR analysis. Relative mRNA expressions of (A) MAPK10, (B) TUBB2B, (C) RASL11B and (D) ITGA2 in the human neuroblastoma SH-SY5Y cell line compared with the hTERT-RPE cell line detected by RT-qPCR. **P<0.01, ***P<0.001 vs. hTERT-RPE cells. RT-qPCR, reverse transcription-quantitative polymerase chain reaction; MAPK10, mitogen-activated protein kinase 10; TUBB2B, tubulin β 2B class IIb; RASL11B, RAS like family 11 member B; ITGA2, integrin subunit α 2.